Related Experiment Video
Updated: Apr 8, 2026
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Epidemiology of Sexual Dysfunction in Iran: A Systematic Review and Meta-analysis
Mohammad Arash Ramezani1, Khodabakhsh Ahmadi1, Afagh Ghaemmaghami2
1Department of Sexual Health, Behavioral Sciences Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Background:
The aim of this study was to determine the cumulative prevalence rate of every sexual dysfunctions (SDs) in Iranian population.
Methods:
We searched international database such as: PubMed/Medline, Scopus, PsychNET, and Scholar Google and Iranian database such as Iran Psych, IranDoc, IranMedex, and SID. Search duration was between 1990 and 2013.
Results:
From 449 articles were retrieved, then 11 articles on male with total sample size of 2142 and 8 articles on female with total sample size of 4391 were selected after critical appraisal. For quality assessment check list to evaluate a prevalence article was contained study population, sampling method, sample size, criteria for SD diagnosis, specific rates, study location, and authors list. In male, erectile dysfunction was 56.1%. In female, pooled estimation prevalence of hypoactive sexual desire disorder in complained group was 65.8% (95% confidence interval [CI]: 51.1-80.6%) compared to general population 35% (95% CI: 17.6-52.1%). Sexual arousal disorder in clinical patient was 59.6% (95% CI: 39-80%) against 33.8% (95% CI: 18.3-49.3%) in general population. Orgasmic disorder in complained was 35.5% (95% CI: 16-55%) and in general population was 35.3% (95% CI: 26.8-43.8%). Sexual pain disorder pooled estimation prevalence were 35.2% (95% CI: 14.5-56%) versus 20.1% (95% CI: 6.4-33.8%) in complained and general population consecutively.
Conclusions:
The rate of SD in Iran was approximately the same of worldwide except orgasmic disorder which was two times more than the worldwide average.